Article citationsMore>>
Kummar, S., et al. (2010) Phase I Trial of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-D.M.A.G.), a Heat Shock Protein Inhibitor, Administered Twice Weekly in Patients with Advanced Malignancies. European Journal of Cancer, 46, 340-347.
https://doi.org/10.1016/j.ejca.2009.10.026
has been cited by the following article:
Related Articles:
-
Abdelkarim S. Allal, Arnaud D. Roth, Alessandra Franzetti-Pellanda, Marta Bonet, Pascal Gervaz, Sabine Bieri
-
Peter Chin Wan Fung, Regina Kit Chee Kong
-
Shiori Yoshida, Fumiko Sato, Keita Tagami, Shin Takahashi
-
Jason T. Kilembe, Albert S. Lundemba, Dikima D. Bibelayi, Glodi M. Ndefi, Juliette Pradon, Zéphyrin G. Yav
-
Wei Zhang, Aldo Becciolini, Annibale Biggeri, Paolo Pacini, Colin R. Muirhead